Advertisers can now utilize Lifescript's first-party database to engage 150 million U.S. consumers across the adtech ecosystem.
NEWPORT BEACH, Calif., Aug. 22, 2017 /PRNewswire/ -- Lifescript, a leading health and wellness publisher and first-party data provider, today announced a partnership with LiveRamp®, an Acxiom® company (NASDAQ: ACXM) and leading provider of omnichannel identity resolution. Through this partnership, Lifescript will make its syndicated and custom audience data segments available for engaging consumers through the data store feature of LiveRamp's IdentityLink™ solution. The partnership means that consumers will have more relevant and accurate messaging experiences based on their declared health interests.
Lifescript manages a proprietary audience of more than 150 million U.S. consumers, inclusive of first-party health-interest data, demographics, and parenting data. Distinguishing itself from traditional providers, Lifescript's contributing data is opted-in, and declared by the user through participation in various surveys, promotional offers, and registrations.
LiveRamp's IdentityLink solution resolves this data to a privacy-compliant consumer identifier leveraged by hundreds of brands and technology platforms for people-based marketing. In so doing, LiveRamp enables Lifescript to activate its data and support brands' people-based marketing initiatives, as well as provide consumers with more relevant and accurate messaging experiences based on their expressed health interests.
"As pharma and health advertisers continue to embrace programmatic strategies, the demand to reach interested consumers across all possible touch points is increasing," said Brian Hogan, COO of Lifescript. "By working with LiveRamp, brands will now be able to reach our declared health-interest audiences, on any site and any device."
Using LiveRamp's IdentityLink™ Data Store, brands and agencies can easily activate Lifescript's data across the broader ecosystem of Demand Side Platforms (DSPs) and other buying platforms for more effective targeting and engagement.
"We are seeing more demand for declared data, especially for specialized audiences such as health interest," said Luke McGuinness, GM of Data Store at LiveRamp. "Lifescript is able to offer interest-based segments within the health vertical, and we're excited to be able to make them available to our brand, agency, and platform clients for people-based marketing."
Lifescript is an award-winning media company focused on women's health and wellness, and manages the largest database of opted-in declared health audiences in the U.S. Our technology and marketing solutions allow us to reach niche audiences, such as condition and symptom interest, across channels and device types. For consumers, Lifescript's digital properties create a place where women discover and share healthy living through engaging and relevant content.
Our platform and data management capabilities enable people-based marketing for some of the world's largest pharmaceutical and CPG brands and their agencies through various online, social, programmatic, and email programs. For more information, visit http://www.lifescript.com.
LiveRamp offers brands and the companies they work with identity resolution that is integrated throughout the digital ecosystem, and provides the foundation for omnichannel marketing. Our services transform the technology platforms used by our clients into people-based marketing channels that improve the relevancy of marketing, and ultimately allow consumers to better connect with the brands and products they love. LiveRamp is an Acxiom company, delivering privacy-safe solutions to market and honoring the best practices of leading associations including the Digital Advertising Alliance's (DAA) ICON and App Choices programs. For more information, visit http://www.LiveRamp.com
Related links: http://www.lifescript.com/
View original content with multimedia:http://www.prnewswire.com/news-releases/lifescript-partners-with-liveramp-to-provide-health-interest-data-for-people-based-marketing-300507403.html
© 2017 PR Newswire. All Rights Reserved.